Biovest is emerging from bankruptcy. They make individualized vaccines for non hodgkins lymphoma. Their products are in use in Europe and have been granted orphan drug status by the FDA.A reorganization plan will be announced any day. Accentia… More
BIOVEST INTERNATIONAL INCORPORATED (OTCBB: BVTI) "Up 3.33% in morning trading"Detailed Quote: http://www.otcpicks.com/quotes/BVTI.phpBiovest International, Inc. is a pioneer in the development of advanced individualized immunotherapies for… More